Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MIBEFRADIL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 169 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Meinertz, T
      Mibefradil - a drug which may enhance the propensity for the development of abnormal QT prolongation

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    2. Glaser, S; Steinbach, M; Opitz, C; Wruck, U; Kleber, FX
      Torsades de pointes caused by Mibefradil

      EUROPEAN JOURNAL OF HEART FAILURE
    3. Rothberg, BEG
      Mapping a role for SNPs in drug development

      NATURE BIOTECHNOLOGY
    4. Gustafsson, F; Andreasen, D; Salomonsson, M; Jensen, BL; Holstein-Rathlou, NH
      Conducted vasoconstriction in rat mesenteric arterioles: role for dihydropyridine-insensitive Ca2+ channels

      AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
    5. Yeo, KR; Yeo, WW
      Inhibitory effects of verapamil and diltiazem on simvastatin metabolism inhuman liver microsomes

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    6. Lotshaw, DP
      Role of membrane depolarization and T-type Ca2+ channels in angiotensin IIand K+ stimulated aldosterone secretion

      MOLECULAR AND CELLULAR ENDOCRINOLOGY
    7. Baylis, C; Qiu, CB; Engels, K
      Comparison of L-type and mixed L- and T-type calcium channel blockers on kidney injury caused by deoxycorticosterone-salt hypertension in rats

      AMERICAN JOURNAL OF KIDNEY DISEASES
    8. Honda, M; Hayashi, K; Matsuda, H; Kubota, E; Tokuyama, H; Okubo, K; Takamatsu, I; Ozawa, Y; Saruta, T
      Divergent renal vasodilator action of L- and T-type calcium antagonists invivo

      JOURNAL OF HYPERTENSION
    9. Ozawa, Y; Hayashi, K; Nagahama, T; Fujiwara, K; Saruta, T
      Effect of T-type selective calcium antagonist on renal microcirculation - Studies in the isolated perfused hydronephrotic kidney

      HYPERTENSION
    10. van Veldhuisen, DJ; Poole-Wilson, PA
      The underreporting of results and possible mechanisms of 'negative' drug trials in patients with chronic heart failure

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    11. Tzivoni, D
      End organ protection by calcium-channel blockers

      CLINICAL CARDIOLOGY
    12. Leuranguer, V; Mangoni, ME; Nargeot, J; Richard, S
      Inhibition of T-type and L-type calcium channels by mibefradil: Physiologic and pharmacologic bases of cardiovascular effects

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    13. Sandmann, S; Claas, R; Cleutjens, JPM; Daemen, MJAP; Unger, T
      Calcium channel blockade limits cardiac remodeling and improves cardiac function in myocardial infarction-induced heart failure in rats

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    14. Honda, M; Hayashi, K; Matsuda, H; Kubota, E; Tokuyama, H; Okubo, K; Ozawa, Y; Saruta, T
      Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis

      CLINICAL SCIENCE
    15. Kuhlmann, J; Muck, W
      Clinical-pharmacological strategies to assess drug interaction potential during drug development

      DRUG SAFETY
    16. Xi, Q; Angus, JA
      Evidence against an action of mibefradil at N-type voltage-operated calcium channels

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    17. Koh, SD; Monaghan, K; Ro, S; Mason, HS; Kenyon, JL; Sanders, KM
      Novel voltage-dependent non-selective cation conductance in murine colonicmyocytes

      JOURNAL OF PHYSIOLOGY-LONDON
    18. Heady, TN; Gomora, JC; Macdonald, TL; Perez-Reyes, E
      Molecular pharmacology of T-type Ca2+ channels

      JAPANESE JOURNAL OF PHARMACOLOGY
    19. Carnes, CA; Chung, MK; Nakayama, T; Nakayama, H; Baliga, RS; Piao, S; Kanderian, A; Pavia, S; Hamlin, RL; McCarthy, PM; Bauer, JA; Van Wagoner, DR
      Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation

      CIRCULATION RESEARCH
    20. Fareh, S; Benardeau, A; Nattel, S
      Differential efficacy of L- and T-type calcium channel blockers in preventing tachycardia-induced atrial remodeling in dogs

      CARDIOVASCULAR RESEARCH
    21. Nilius, B; Prenen, J; Vennekens, R; Hoenderop, JGJ; Bindels, RJM; Droogmans, G
      Pharmacological modulation of monovalent cation currents through the epithelial Ca2+ channel ECaC1

      BRITISH JOURNAL OF PHARMACOLOGY
    22. Klotz, U; Sailer, D
      Drug interactions - their impact on safe drug therapy as exemplified by the novel group of thiazolidinediones (glitazones)

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    23. Petkov, GV; Fusi, F; Saponara, S; Gagov, HS; Sgaragli, GP; Boev, KK
      Characterization of voltage-gated calcium currents in freshly isolated smooth muscle cells from rat tail main artery

      ACTA PHYSIOLOGICA SCANDINAVICA
    24. Sandmann, S; Bohle, RM; Dreyer, T; Unger, T
      The T-type calcium channel blocker mibefradil reduced interstitial and perivascular fibrosis and improved hemodynamic parameters in myocardial infarction-induced cardiac failure in rats

      VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    25. Marsh, JD; Antman, EM
      T-type calcium channel blockade in the management of chronic ischemic heart disease

      CARDIOVASCULAR DRUGS AND THERAPY
    26. Tzivoni, D; Gilula, Z; Klutstein, MW; Reisin, L; Botvin, S; Kobrin, I
      The effect of mibefradil on ischemic episodes with and without increase inheart rate

      CARDIOVASCULAR DRUGS AND THERAPY
    27. Chung, O; Hinder, M; Sharma, AM; Bonner, G; Middeke, M; Platon, J; Unger, T
      Comparison of the efficacy and safety of losartan (50-100 mg) with the T-type calcium channel blocker mibefradil (50-1100 mg) in mild to moderate hypertension

      FUNDAMENTAL & CLINICAL PHARMACOLOGY
    28. Sevanian, A; Shen, LJ; Ursini, F
      Inhibition of LDL oxidation and oxidized LDL-induced cytotoxicity by dihydropyridine calcium antagonists

      PHARMACEUTICAL RESEARCH
    29. Petrov, V; Lijnen, P
      Inhibition of proliferation of human peripheral blood mononuclear cells bycalcium antagonists. Role of interleukin-2

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    30. Manolopoulos, VG; Liekens, S; Koolwijk, P; Voets, T; Peters, E; Droogmans, G; Lelkes, PI; De Clercq, E; Nilius, B
      Inhibition of angiogenesis by blockers of volume-regulated anion channels

      GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM
    31. Angus, J; Sarsero, D; Fujiwara, T; Molenaar, P; Xi, Q
      Quantitative analysis of vascular to cardiac selectivity of L- and T-type voltage-operated calcium channel antagonists in human tissues

      CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
    32. Rothberg, BEG; Ramesh, TM; Burgess, CE
      Integrating expression-based drug response and SNP-based pharmacogenetic strategies into a single comprehensive pharmacogenomics program

      DRUG DEVELOPMENT RESEARCH
    33. Lacinova, L; Klugbauer, N; Hofmann, F
      Low voltage activated calcium channels: from genes to function

      GENERAL PHYSIOLOGY AND BIOPHYSICS
    34. Tjeerdsma, G; Brouwer, J; de Kam, PJ; Haaksma, J; Crijns, HJGM; van Veldhuisen, DJ
      Effect of mibefradil on heart rate variability in patients with chronic heart failure

      INTERNATIONAL JOURNAL OF CARDIOLOGY
    35. Lory, P; Monteil, A; Chemin, J; Leuranguer, V; Bourinet, E; Nargeot, J
      Molecular diversity of voltage-gated calcium channels

      THERAPIE
    36. Kuhar, CG; Budihna, MV
      Effects of mibefradil and verapamil on ischemic-reperfusion in the hearts of guinea pigs with acute renal failure

      PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
    37. Martinuc, J; Drevensek, G; Budihna, MV
      Action of mibefradil and lacidipine on the isolated human anterior tibial artery

      PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
    38. Arh, M; Budihna, MV
      Comparison of effects of nitrendipine, lacidipine and mibefradil on postischaemic myocardial damage in isolated rat hearts

      PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
    39. Lacinova, L; Klugbauer, N; Hofmann, F
      Regulation of the calcium channel alpha(1G) subunit by divalent cations and organic blockers

      NEUROPHARMACOLOGY
    40. Matthes, J; Huber, I; Haaf, O; Antepohl, W; Striessnig, J; Herzig, S
      Pharmacodynamic interaction between mibefradil and other calcium channel blockers

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    41. Perchenet, L; Bernardeau, A; Ertel, EA
      Pharmacological properties of Ca(v)3.2, a low voltage-activated Ca2+ channel cloned from human heart

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    42. van der Lee, R; Pfaffendorf, M; De Mey, JGR; van Zwieten, PA
      Inhibitory effect of mibefradil on contractions induced by sympathetic neurotransmitter release in the rat tail artery

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    43. Rinaldi, G; Navia, D; Vaccarino, G; Segura, E; Albertal, J
      Vasodilators in isolated human radial arteries.

      MEDICINA-BUENOS AIRES
    44. Paneitz, A; Meissner, K; Kroemer, HK
      Drug interactions: New mechanisms and clinical relevance

      INTERNIST
    45. Chemin, J; Monteil, A; Briquaire, C; Richard, S; Perez-Reyes, E; Nargeot, J; Lory, P
      Overexpression of T-type calcium channels in HEK-293 cells increases intracellular calcium without affecting cellular proliferation

      FEBS LETTERS
    46. McNaughton, NCL; Warre, R; Cooper, DG; Nasir, S; Ranson, JL; Randall, A
      Potent inhibition of a recombinant low voltage-activated Ca2+ channel by SB-209712

      EUROPEAN JOURNAL OF PHARMACOLOGY
    47. Protas, L; Robinson, RB
      Mibefradil, an I-Ca,I-T blocker, effectively blocks I-Ca,I-L in rabbit sinus node cells

      EUROPEAN JOURNAL OF PHARMACOLOGY
    48. Heubach, JF; Kohler, A; Wettwer, E; Ravens, U
      T-type and tetrodotoxin-sensitive Ca2+ currents coexist in guinea pig ventricular myocytes and are both blocked by mibefradil

      CIRCULATION RESEARCH
    49. Levine, TB; Bernink, PJLM; Caspi, A; Elkayam, U; Geltman, EM; Greenberg, B; McKenna, WJ; Ghali, JK; Giles, TD; Marmor, A; Reisin, LH; Ammon, S; Lindberg, E
      Effect of mibefradil, a T-type calcium channel blocker, on morbidity and mortality in moderate to severe congestive heart failure - The MACH-1 study

      CIRCULATION
    50. Molderings, GJ; Likungu, J; Gothert, M
      N-type calcium channels control sympathetic neurotransmission in human heart atrium

      CIRCULATION
    51. Huang, BY; Qin, DY; Deng, LL; Boutjdir, M; El-Sherif, N
      Reexpression of T-type Ca2+ channel gene and current in post-infarction remodeled rat left ventricle

      CARDIOVASCULAR RESEARCH
    52. Eller, P; Berjukov, S; Wanner, S; Huber, I; Hering, S; Knaus, HG; Toth, G; Kimball, SD; Striessnig, J
      High affinity interaction of mibefradil with voltage-gated calcium and sodium channels

      BRITISH JOURNAL OF PHARMACOLOGY
    53. Terland, O; Flatmark, T
      Energy-dependent accumulation of calcium antagonists in catecholamine storage vesicles

      BIOCHEMICAL PHARMACOLOGY
    54. Clozel, JP; Ertel, EA; Ertel, SI
      Voltage-gated T-type Ca2+ channels and heart failure

      PROCEEDINGS OF THE ASSOCIATION OF AMERICAN PHYSICIANS
    55. Pinto, JMB; Sosunov, EA; Gainullin, RZ; Rosen, MR; Boyden, PA
      Effects of mibefradil, a T-type calcium current antagonist, on electrophysiology of Purkinje fibers that survived in the infarcted canine heart

      JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
    56. Paquette, F; Jasmin, G; Dumont, L
      Cardioprotective efficacy of verapamil and mibefradil in young UM-X7.1 cardiomyopathic hamsters

      CARDIOVASCULAR DRUGS AND THERAPY
    57. Behrends, M; Schulz, R; Heusch, G
      Effects of verapamil and mibefradil on regional blood flow and function innormal and ischemic myocardium

      CARDIOVASCULAR DRUGS AND THERAPY
    58. Mocanu, MM; Gadgil, S; Yellon, DM; Baxter, GF
      Mibefradil, a T-type and L-type calcium channel blocker, limits infarct size through a glibenclamide-sensitive mechanism

      CARDIOVASCULAR DRUGS AND THERAPY
    59. van der Lee, R; Pfaffendorf, M; van Zwieten, PA
      Comparative effects of mibefradil and other calcium antagonists on resistance arteries of different end organs

      FUNDAMENTAL & CLINICAL PHARMACOLOGY
    60. Becquemont, L; Funck-Brentano, C; Jaillon, P
      Mibefradil, a potent CYP3A inhibitor, does not alter pravastatin pharmacokinetics

      FUNDAMENTAL & CLINICAL PHARMACOLOGY
    61. Fuhr, U
      "Clinically relevant" new drug interactions

      MEDIZINISCHE KLINIK
    62. Lijnen, P; Petrov, V
      Proliferation of human peripheral blood mononuclear cells during calcium entry blockade. Role of protein kinase C

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    63. Peters, J; Welker, HA; Bullingham, R
      Pharmacokinetic and pharmacodynamic aspects of concomitant mibefradil-digoxin therapy at therapeutic doses

      EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
    64. Prueksaritanont, T; Ma, B; Tang, CY; Meng, Y; Assang, C; Lu, P; Reider, PJ; Lin, JH; Baillie, TA
      Metabolic interactions between mibefradil and HMG-CoA reductase inhibitors: an in vitro investigation with human liver preparations

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    65. Qiu, CB; Bruneval, P; Roeckel, A; Heudes, D; Van Huyen, JPD; Roux, S
      Mibefradil prevents L-NAME-exacerbated nephrosclerosis in spontaneously hypertensive rats

      JOURNAL OF HYPERTENSION
    66. Wagner, C; Hinder, M; Kramer, BK; Kurtz, A
      Role of renal nerves in the stimulation of the renin system by reduced renal arterial pressure

      HYPERTENSION
    67. Karam, H; Clozel, JP; Bruneval, P; Gonzalez, MF; Menard, J
      Contrasting effects of selective T- and L-type calcium channel blockade onglomerular damage in DOCA hypertensive rats

      HYPERTENSION
    68. Nakamura, Y; Ono, H; Frohlich, ED
      Differential effects of T- and L-type calcium antagonists on glomerular dynamics in spontaneously hypertensive rats

      HYPERTENSION
    69. Lijnen, P; Fagard, R; Petrov, V
      Mibefradil-induced inhibition of proliferation of human peripheral blood mononuclear cells

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    70. Martina, B; Lorz, W; Frach, B; Bart, T; Battegay, EJ
      The effects of mibefradil and enalapril on 24-hour blood pressure control and left ventricular mass in patients with mild to moderate hypertension: Double-blind, randomized trial

      JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
    71. Manso, AM; Encabo, A; Ferrer, M; Balfagon, G; Salaices, M; Marin, J
      Changes of cardiac calcium homeostasis in spontaneously hypertensive rats

      JOURNAL OF AUTONOMIC PHARMACOLOGY
    72. Friedman, MA; Woodcock, J; Lumpkin, MM; Shuren, JE; Hass, AE; Thompson, LJ
      The safety of newly approved medicines - Do recent market removals mean there is a problem?

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    73. Huang, SM; Lesko, LJ; Williams, RL
      Assessment of the quality and quantity of drug-drug interaction studies inrecent NDA submissions: Study design and data analysis issues

      JOURNAL OF CLINICAL PHARMACOLOGY
    74. Ocran, KW; Plauth, M; Mai, I; Lochs, H
      Tacrolimus toxicity due to drug interaction with mibefradil in a patient after liver transplantation

      ZEITSCHRIFT FUR GASTROENTEROLOGIE
    75. Krayenbuhl, JC; Vozeh, S; Kondo-Oestreicher, M; Dayer, P
      Drug-drug interactions of new active substances: mibefradil example

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    76. Lijnen, P; Fagard, R; Petrov, V
      Cytosolic calcium and lymphoproliferative response during calcium antagonism in men

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    77. Martina, B; Frach, B; Surber, C; Drewe, J; Battegay, E; Gasser, P
      Capillary blood cell velocity in finger nailfold: Effect of enalapril and mibefradil in patients with mild to moderate hypertension

      MICROVASCULAR RESEARCH
    78. Williams, ME; Washburn, MS; Hans, M; Urrutia, A; Brust, PF; Prodanovich, P; Harpold, MM; Stauderman, KA
      Structure and functional characterization of a novel human low-voltage activated calcium channel

      JOURNAL OF NEUROCHEMISTRY
    79. Ruschitzka, FT; Noll, G; Luscher, TF
      Calcium antagonists - Results of recent studies and their significance forpractice

      INTERNIST
    80. Lapointe, N; Chen, H; Qi, S; Xu, D; Daloze, P; Dumont, L
      Immunomodulating effects of second-generation calcium channel blockers on experimental heart transplantation

      EUROPEAN SURGICAL RESEARCH
    81. Reimer, KA; Califf, RM
      Good news for experimental concept but bad news for clinically effective therapy

      CIRCULATION
    82. Schulz, R; Post, H; Jalowy, A; Backenkohler, U; Dorge, H; Vahlhaus, C; Heusch, G
      Unique cardioprotective action of the new calcium antagonist mibefradil

      CIRCULATION
    83. Sandmann, S; Min, JY; Meissner, A; Unger, T
      Effects of the calcium channel antagonist mibefradil on haemodynamic parameters and myocardial Ca2+-handling in infarct-induced heart failure in rats

      CARDIOVASCULAR RESEARCH
    84. Farkas, A; Qureshi, A; Curtis, MJ
      Inadequate ischaemia-selectivity limits the antiarrhythmic efficacy of mibefradil during regional ischaemia and reperfusion in the rat isolated perfused heart

      BRITISH JOURNAL OF PHARMACOLOGY
    85. Liu, JH; Bijlenga, P; Occhiodoro, T; Fischer-Lougheed, J; Bader, CR; Bernheim, L
      Mibefradil (Ro40-5967) inhibits several Ca2+ and K+ currents in human fusion-competent myoblasts

      BRITISH JOURNAL OF PHARMACOLOGY
    86. BILLUPS SJ; CARTER BL
      MIBEFRADIL - A NEW CLASS OF CALCIUM-CHANNEL ANTAGONISTS

      The Annals of pharmacotherapy
    87. SPOENDLIN M; PETERS J; WELKER H; BOCK A; THIEL G
      PHARMACOKINETIC INTERACTION BETWEEN ORAL CYCLOSPORINE AND MIBEFRADIL IN STABILIZED POST-RENAL-TRANSPLANT PATIENTS

      Nephrology, dialysis, transplantation
    88. Lijnen, P; Fagard, R; Petrov, V
      Proliferation of human peripheral blood mononuclear cells during calcium channel blockade

      AMERICAN JOURNAL OF HYPERTENSION
    89. Emanuel, K; Mackiewicz, U; Pytkowski, B; Lewartowski, B
      Effects of mibefradil, a blocker of T-type Ca2+ channels, in single myocytes and intact muscle of guinea-pig heart

      JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
    90. WOITTIEZ AJJ; HUYSMANS FTM; BAILEY R; ROBSON RA; MION D; VILLA G; KOBRIN I
      A COMPARISON OF THE SAFETY AND EFFICACY OF MIBEFRADIL AND NIFEDIPINE SR IN PATIENTS WITH RENAL-DISEASE AND HYPERTENSION

      Clinical nephrology
    91. BAO JP; LI JJ; PERL ER
      DIFFERENCES IN CA2-I AND LAMINAE-II( CHANNELS GOVERNING GENERATION OFMINIATURE AND EVOKED EXCITATORY SYNAPTIC CURRENTS IN SPINAL LAMINAE)

      The Journal of neuroscience
    92. CAO ZM; HULTHEN UL; ALLEN TJ; COOPER ME
      ANGIOTENSIN-CONVERTING ENZYME-INHIBITION AND CALCIUM ANTAGONISM ATTENUATE STREPTOZOTOCIN-DIABETES-ASSOCIATED MESENTERIC VASCULAR HYPERTROPHY INDEPENDENTLY OF THEIR HYPOTENSIVE ACTION

      Journal of hypertension
    93. FRISHMAN WH; BITTAR N; GLASSER S; HABIB G; SMITH W; PORDY R
      ADDITIONAL ANTIANGINAL AND ANTIISCHEMIC EFFICACY OF MIBEFRADIL IN PATIENTS CONCOMITANTLY TREATED WITH LONG-ACTING NITRATES FOR CHRONIC STABLE ANGINA-PECTORIS

      Clinical cardiology
    94. Massie, BM
      The safety of calcium-channel blockers

      CLINICAL CARDIOLOGY
    95. HOISCHEN S; BRIXIUS K; SCHWINGER RHG
      T-TYPE AND L-TYPE CA2-CHANNEL ANTAGONISTS REDUCE CONTRACTILITY IN GUINEA-PIG CARDIAC MYOCYTES()

      Journal of cardiovascular pharmacology
    96. WELKER HA; WEIDEKAMM E; HOUWING N; DECHATEL R
      PHARMACOKINETICS AND PHARMACODYNAMICS OF MIBEFRADIL IN HYPERTENSIVE PATIENTS WITH VARYING DEGREES OF RENAL-INSUFFICIENCY

      Pharmacology
    97. LEONHARDT W; LANGE M
      ANTIOXIDATIVE ACTION OF THE NOVEL CALCIUM-CHANNEL ANTAGONIST MIBEFRADIL ON LOW-DENSITY LIPOPROTEINS

      European Journal of Clinical Pharmacology
    98. Heitmann, J; Grote, L; Knaack, L; Kohler, U; Hinder, M; Peter, JH
      Cardiovascular effects of mibefradil in hypertensive patients with obstructive sleep apnea

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    99. Krum, H; McNeil, JJ
      The short life and rapid death of a novel antihypertensive and antianginalagent

      MEDICAL JOURNAL OF AUSTRALIA
    100. Rossier, MF; Ertel, EA; Vallotton, MB; Capponi, AM
      Inhibitory action of mibefradil on calcium signaling and aldosterone synthesis in bovine adrenal glomerulosa cells

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/08/20 alle ore 03:40:24